Exelixis
EXEL
#2109
Rank
A$11.30 B
Marketcap
$39.63
Share price
-1.53%
Change (1 day)
18.25%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

Exelixis (EXEL) - Net assets

Net assets on the balance sheet as of June 2024 : A$3.17 B

According to Exelixis's latest financial reports the company has A$3.17 B in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Exelixis - Net assets on balance sheet (from 2001 to 2024)

Net assets by year

Year Net assets Change
2023-12-31$A$3.32 B-9.13%
2022-12-31$A$3.65 B20.28%
2021-12-31$A$3.04 B24.67%
2020-12-31$A$2.43 B1.68%
2019-12-31$A$2.39 B31.28%
2018-12-31$A$1.82 B400.51%
2017-12-31$A$0.36 B194.57%
2016-12-31$A$0.12 B-164.1%
2015-12-31$-A$0.2 B38.04%
2014-12-31$-A$0.15 B-288.57%
2013-12-31$A$74.26 M-74.03%
2012-12-31$A$0.28 B223.46%
2011-12-31$A$88.39 M-139.19%
2010-12-31$-A$0.23 B23.19%
2009-12-31$-A$0.19 B124.72%
2008-12-31$-A$81.47 M-183.24%
2007-12-31$A$97.86 M-14.86%
2006-12-31$A$0.11 B46.79%
2005-12-31$A$78.3 M19.59%
2004-12-31$A$65.47 M-69.86%
2003-12-31$A$0.21 B-30.42%
2002-12-31$A$0.31 B-32.82%
2001-12-31$A$0.46 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
A$26.13 B 721.92%๐Ÿ‡ฌ๐Ÿ‡ง UK
A$117.36 B 3,591.58%๐Ÿ‡ซ๐Ÿ‡ท France
A$65.46 B 1,959.13%๐Ÿ‡บ๐Ÿ‡ธ USA
A$25.60 B 705.24%๐Ÿ‡บ๐Ÿ‡ธ USA
A$8.88 B 179.52%๐Ÿ‡บ๐Ÿ‡ธ USA
A$107.29 B 3,274.86%๐Ÿ‡บ๐Ÿ‡ธ USA
A$131.95 B 4,050.29%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$1.05 M-100.03%๐Ÿ‡บ๐Ÿ‡ธ USA
A$43.26 M-98.64%๐Ÿ‡บ๐Ÿ‡ธ USA